113 results on '"G. Brembilla"'
Search Results
2. Are men with low risk prostate cancer but high pirads score lesions at mp-MRI still candidate for active surveillance? Results from a large, multi-institutional radical prostatectomy series
3. Age and Gleason score upgrading between prostate biopsy and radical prostatectomy. Is this still true in the mp-MRI era?
4. The current role of renal tumour biopsy in the management of patients with suspected renal cancer: a prospective observational study
5. How can we increase the positive predictive value of PIRADS 4 and 5 lesions at mp-MRI? Development of a novel prediction tool relying on a large, multi-institutional series
6. Are men with low risk prostate cancer but high PIRADS score lesions at mp-MRI still candidate for active surveillance? Results from a large, multi-institutional radical prostatectomy series
7. Multiparametric MRI of the prostate significantly underestimates tumor volume of small visible lesions. Implications for tailored focal therapy approaches
8. Clinical benefit and cost-effectiveness of a biopsy-all strategy in patients diagnosed with renal mass: Simulation of a randomized controlled trial
9. Pre-operative risk calculator for the probability of completing surgery for kidney cancer: The key role of tumour complexity and surgical experience
10. Does prostate cancer family history have an impact on active surveillance adherence in men with low- or favourable intermediate risk disease?
11. Detection of pulmonary lesion during follow-up after surgery for localized renal cell carcinoma: Disease progression or a primary lung cancer?
12. Is there an impact of the center performing baseline multiparametric MRI on active surveillance outcomes in prostate cancer patients?
13. Defining the most useful intermediate endpoint for overall survival in intermediate and high-risk clear cell carcinoma
14. The current role of renal tumor biopsy in the management of small renal masses: Long-term results from a prospective, single-institutional database
15. 68Ga-PSMA PET radiomics for the prediction of post-surgical ISUP grade in primary prostate cancer patients
16. Impact of radiologist expertise on PI-RADS distribution and detection of clinically significant prostate cancer: Results from a single, high volume center
17. Is there a preferential lymph node metastasis pathway in prostate cancer according to the site of the index lesion at multiparametric MRI? A topographic mapping study
18. Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy
19. Imaging intensity after surgery for clear cell renal cell carcinoma
20. Impact of Prostate Imaging Quality (PI-QUAL) score on the detection of clinically significant prostate cancer in men undergoing MRI-targeted biopsy
21. Defining the optimal target-to-background count rate to identify positive lymph nodes in patients undergoing robot-assisted 99mtc-PSMA-radioguided surgery for prostate cancer: A per-region analysis of a prospective, phase II study
22. A novel model Integrating clinical, mp-MRI, and epigenomic features to predict lymph node invasion in prostate cancer patients undergoing radical prostatectomy and pelvic lymph node dissection
23. Concordance of renal sinus or calyces invasion between preoperative imaging and final pathology after surgery for kidney cancer
24. Utility of pre- and post-pembrolizumab (Pembro) Vesical Imaging–Reporting and Data System (VI-RADS) to predict the pathological response in muscle-invasive urothelial bladder cancer (MIBC): An analysis of the PURE-01 cohort
25. Detection of clinically significant prostate cancer in mpMRI visible lesions: size matters. Results from a large, two-institutional series
26. Has the introduction of mpMRI in the diagnostic pathway of prostate cancer led to improved oncological outcomes after radical prostatectomy? Result from a large single-institutional series
27. Does previous prostatic surgery affect the accuracy of multiparametric MRI in detecting clinically significant prostate cancer? Results from a single center, high volume series
28. Detection of clinically significant prostate cancer in mpMRI visible lesions: Size matters. Results from a large, two-institutional series
29. Pancreatic metastases after surgery for renal cell carcinoma
30. When to de-intensify oncologic surveillance scheme for non-clear cell renal cell carcinoma
31. Does a positive multi-parametric MRI always warrant prostate biopsy? The importance of integrating clinical and imaging data based on a large, multi-institutional series
32. Prostate cancers detected at multi-parametric MRI targeted versus systematic biopsies: are they equal? Results from a large multi-institutional series
33. Development and external validation of a novel tool predicting lymph node invasion in patients with prostate cancer detected at targeted-biopsies
34. Saturation of the MPMRI lesion is not necessary to minimize the risk of missing clinically significant prostate cancer at targeted biopsy. Analysis of a large, multi-institutional series
35. Should we routinely recommend a central review of magnetic resonance imaging of the prostate in men with positive mp-MRI? Implication for targeted biopsies
36. The learning curve of mpMRI targeted biopsy for the detection of clinically significant prostate cancer is related to the characteristics of the index lesion
37. Optimizing the number of systematic cores during an MRI target biopsy: Preliminary results from the prospective, single center SCOT Trial (NCT 04183699)
38. The learning curve of mpMRI targeted biopsy for the detection of clinically significant prostate cancer is related to the characteristics of the index lesion
39. Identifying the optimal clinical setting for the use of multiparametric magnetic resonance imaging of the prostate as local staging tool in men candidate to radical prostatectomy. Results from a multi-institutional series
40. The detection of a PI-RADS 4–5 lesion at multiparametric MRI before confirmatory biopsy is the strongest predictor of disease progression among men with low-risk prostate cancer included in an active surveillance prospective protocol
41. Ultra-fast biparametric MRI for prostate cancer detection
42. Prise en charge de la dyspnée aiguë suspecte d’insuffisance cardiaque en urgence : un challenge diagnostique et thérapeutique
43. Clinical features of a fatal shoulder dystocia: The hypovolemic shock hypothesis
44. P12.01: Latrogenic monoamnionicity after laser treatment for Twin–twin transfusion syndrome: risk factors, prognosis and outcome
45. OP02.02: Accuracy of prenatal imaging in the diagnosis of vascular anomalies
46. There is no way to avoid concomitant systematic prostate biopsies in addition to mp-MRI targeted sampling in men with positive imaging
47. Should we rely on multiparametric MRI of the prostate performed at non-academic centres? Implications for optimized target biopsy approaches
48. Assessing the impact of radiologist expertise on the misdiagnosis of clinically significant prostate cancer among men receiving multi-parametric MRI
49. [The network of health promoting companies (WHP) in the province of Bergamo]
50. [Courses for smoking cessation in the workplaces: results and opportunities]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.